Cargando…

Ameloblastoma: Management and Outcome

Introduction Ameloblastoma is a locally destructive tumor with a propensity for recurrence if not entirely excised. Management of ameloblastoma poses a challenge for all involved in the field of head and neck surgery because successful treatment requires not only adequate resection but also a functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Adeel, Mohammad, Rajput, Muhammad Shaheryar Ahmed, Arain, Asif Ali, Baloch, Maqbool, Khan, Mumtaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289562/
https://www.ncbi.nlm.nih.gov/pubmed/30546984
http://dx.doi.org/10.7759/cureus.3437
_version_ 1783379979329863680
author Adeel, Mohammad
Rajput, Muhammad Shaheryar Ahmed
Arain, Asif Ali
Baloch, Maqbool
Khan, Mumtaz
author_facet Adeel, Mohammad
Rajput, Muhammad Shaheryar Ahmed
Arain, Asif Ali
Baloch, Maqbool
Khan, Mumtaz
author_sort Adeel, Mohammad
collection PubMed
description Introduction Ameloblastoma is a locally destructive tumor with a propensity for recurrence if not entirely excised. Management of ameloblastoma poses a challenge for all involved in the field of head and neck surgery because successful treatment requires not only adequate resection but also a functional and aesthetically acceptable reconstruction of the residual defect. Methods Patients who had histologically proven ameloblastoma between 1991 and 2009 were identified from the database of Aga Khan University Hospital. A review of all medical records, radiological images, operative reports and pathology reports was undertaken. Results A total of 15 patients with histologically confirmed ameloblastoma were identified. Out of 15 patients nine were males and six were females with age range from 20 to 60 years (mean age 43 years). The most common symptom found in our patient group was painless facial swelling. In 13 patients the origin of tumor was mandible and in the remaining two the tumor originated from maxilla. Eleven out of 15 patients underwent segmental mandibulectomy, two had maxillectomy and two had enucleation. All patients who underwent segmental mandibulectomy required reconstruction. Reconstruction was done with microsurgical free tissue transfer in eight patients, non-vascularized iliac crest bone graft was used in one patient and two had plating only. All free flaps survived with no evidence of flap loss. The mean follow-up was eight years. There was no evidence of graft failure which was used in one patient. Complication was seen in only one of our patients in the form of plate exposure. Recurrence was seen in two of our cases who primarily underwent enucleation. All patients had satisfactory speech, cosmesis and mastication. Conclusion The management of ameloblastoma still poses a big challenge in spite of being the most common odontogenic tumor. In our study we have found that segmental mandibulectomy with disease-free margin of around 1 cm and immediate reconstruction with free tissue transfer have shown good results.
format Online
Article
Text
id pubmed-6289562
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-62895622018-12-13 Ameloblastoma: Management and Outcome Adeel, Mohammad Rajput, Muhammad Shaheryar Ahmed Arain, Asif Ali Baloch, Maqbool Khan, Mumtaz Cureus Otolaryngology Introduction Ameloblastoma is a locally destructive tumor with a propensity for recurrence if not entirely excised. Management of ameloblastoma poses a challenge for all involved in the field of head and neck surgery because successful treatment requires not only adequate resection but also a functional and aesthetically acceptable reconstruction of the residual defect. Methods Patients who had histologically proven ameloblastoma between 1991 and 2009 were identified from the database of Aga Khan University Hospital. A review of all medical records, radiological images, operative reports and pathology reports was undertaken. Results A total of 15 patients with histologically confirmed ameloblastoma were identified. Out of 15 patients nine were males and six were females with age range from 20 to 60 years (mean age 43 years). The most common symptom found in our patient group was painless facial swelling. In 13 patients the origin of tumor was mandible and in the remaining two the tumor originated from maxilla. Eleven out of 15 patients underwent segmental mandibulectomy, two had maxillectomy and two had enucleation. All patients who underwent segmental mandibulectomy required reconstruction. Reconstruction was done with microsurgical free tissue transfer in eight patients, non-vascularized iliac crest bone graft was used in one patient and two had plating only. All free flaps survived with no evidence of flap loss. The mean follow-up was eight years. There was no evidence of graft failure which was used in one patient. Complication was seen in only one of our patients in the form of plate exposure. Recurrence was seen in two of our cases who primarily underwent enucleation. All patients had satisfactory speech, cosmesis and mastication. Conclusion The management of ameloblastoma still poses a big challenge in spite of being the most common odontogenic tumor. In our study we have found that segmental mandibulectomy with disease-free margin of around 1 cm and immediate reconstruction with free tissue transfer have shown good results. Cureus 2018-10-10 /pmc/articles/PMC6289562/ /pubmed/30546984 http://dx.doi.org/10.7759/cureus.3437 Text en Copyright © 2018, Adeel et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Otolaryngology
Adeel, Mohammad
Rajput, Muhammad Shaheryar Ahmed
Arain, Asif Ali
Baloch, Maqbool
Khan, Mumtaz
Ameloblastoma: Management and Outcome
title Ameloblastoma: Management and Outcome
title_full Ameloblastoma: Management and Outcome
title_fullStr Ameloblastoma: Management and Outcome
title_full_unstemmed Ameloblastoma: Management and Outcome
title_short Ameloblastoma: Management and Outcome
title_sort ameloblastoma: management and outcome
topic Otolaryngology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289562/
https://www.ncbi.nlm.nih.gov/pubmed/30546984
http://dx.doi.org/10.7759/cureus.3437
work_keys_str_mv AT adeelmohammad ameloblastomamanagementandoutcome
AT rajputmuhammadshaheryarahmed ameloblastomamanagementandoutcome
AT arainasifali ameloblastomamanagementandoutcome
AT balochmaqbool ameloblastomamanagementandoutcome
AT khanmumtaz ameloblastomamanagementandoutcome